The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
In vivo monoamine oxidase inhibition by d-amphetamine
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, AMP inhibits monoamine oxidase (MAO) activity (79, 90), which decreases cytosolic monoamine breakdown.”
Citations
Cites
Some observations upon a new inhibitor of monoamine oxidase in brain tissue
Johnston, J. P. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90066-x · Cited by 1,597
Heikkila, R. E., Orlansky, H., & Cohen, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90152-5 · Cited by 468
Roth, R. H., Murrin, L. C., & Walters, J. R. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90268-5 · Cited by 364
Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs
Neff, N. H., & Yang, H. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90089-7 · Cited by 333
Ferris, R. M., Tang, F. L. M., & Maxwell, R. A. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29222-9 · Cited by 302
Monoamine Oxidase and its Inhibition.
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-1-123_1 · Cited by 263
Westerink, B. H. C., & Korf, J. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90331-9 · Cited by 240
Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase
Donnelly, C. H., & Murphy, D. L. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90398-7 · Cited by 238
Millennium Cohort Study: Age 17, Sweep 7, 2018
University of London, I. O. E. (2021) · VocBench (University of Rome Tor Vergata) · doi:10.5255/ukda-sn-8682-2 · Cited by 206
Murphy, G. F., Robinson, D. S., & Sharman, D. F. (1969) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1969.tb08308.x · Cited by 198
Research works printed but not linked: 11
- Ziance, 1972, J. Pharmac. exp. Ther., 182, 284
- Houslay, 1976, Life Sci., 19, 467, 10.1016/0024-3205(76)90224-1 · DOI
- Callingham, 1977, Br. J. Pharmac., 61, 470P
- Miller, 1978, Commun. Psychopharmac., 2, 319
- Dial, 1977, Res. Commun. Chem. Path. Pharmac., 17, 145
- Roffler-Tarlov, 1971, Kr. J. Pharmac., 42, 343
- Demarest, 1978, Pharmacologist, 20, 217
- Iverson, 1965, J. Pharmac. exp. Ther., 150, 173
- Elchisak, 1976, Psychopharmac. Commun., 2, 411
- Ferris, 1972, J. Pharmac. exp. Ther., 181, 407
- Miller, 1977, Pharmacologist, 19, 239
Cited by
Sorted by citations
Items 101–120 of 120
Everett, T. J., Eyck, T. W. T., Wu, C., Shelowitz, A. L., Stansbury, S. M., Firek, A., Setlow, B., & McIntyre, J. C. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231219058 · Cited by 6
“Cocaine and amphetamine are both considered psychostimulants but they are pharmacodynami-cally (Calipari et al., 2015; Kahlig and Galli, 2003; Sulzer, 2011) and pharmacokinetically distinct (Chiu and Schenk, 2012; Mantle et al., 1976; Miller et al., 1980).”
BackgroundOh, K., Kim, H.-S., & Wagner, G. C. (1997) · Archives of Pharmacal Research · doi:10.1007/bf02973952 · Cited by 6
Tateyama, M., Ohta, S., Nagao, T., Hirobe, M., & Ono, H. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90184-5 · Cited by 5
Campbell, J. M., Gilmore, D. P., Russell, D., Growney, C. A., Favor, G., Kennedy, A. K., Davies, R. W., Payne, P., & Stone, T. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00251-7 · Cited by 5
Monoamine Oxidase Inhibitors in Parkinson’s Disease
Sandler, M., & Glover, V. A. S. (1989) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-73899-9_15 · Cited by 5
Segat, H. J., Martini, F., Roversi, K., Rosa, S. G., Müller, S. G., Rossato, D. R., Nogueira, C. W., & Bürger, M. E. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113804 · Cited by 4
Devoto, P., Montis, M. G. D., & Tagliamonte, A. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90571-y · Cited by 4
Monoamine oxidase inhibition by d-amphetamine in ganglia and nerve endings
Filinger, E. J., & Stefano, F. J. E. (1982) · Cellular and Molecular Life Sciences · doi:10.1007/bf01972307 · Cited by 3
Interactions of Cannabis and Amphetamine-Type Stimulants
Tambaro, S., & Bortolato, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_16 · Cited by 4
“A third mechanism that contributes to the enhancement of extracellular DA levels by AMPH and METH is afforded by their inhibition of MAOs, which catalyze the metabolism of DA and other monoamines [46, 47].”
Background(1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb17352.x · Cited by 3
Methamphetamine Modulates Functional Connectivity Signatures of Sustained Attention and Arousal
Lyu, Y., Corriveau, A., Molla, H. M., de Wit, H., & Rosenberg, M. D. (2025) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2025.11.005 · Cited by 3
Connors, N. J., & Hoffman, R. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-20790-2_4-1 · Cited by 2
Amphetamines and Their Derivatives
Connors, N. J., & Hoffman, R. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-17900-1_4 · Cited by 2
Tateyama, M. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90107-e · Cited by 2
Reciprocal effects of single or repeated exposure to methylphenidate or sex in adult male rats
Pallikaras, V., Cionnaith, C. E. M., Rosales, V. C. F., Arvanitogiannis, A., & Pfaus, J. G. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06300-8 · Cited by 1
“However, amphetamine also increases the release of these monoamines by other processes, including monoamine oxidase inhibition (Childress et al. 2019; Miller et al. 1980).”
BackgroundNeugebauer, N. M. (2008) · UKnowledge (University of Kentucky) · Cited by 1
Watanabe, H., Tateyama, M., Nagao, T., Ohta, S., Hirobe, M., & Ono, H. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90375-r · Cited by 1
(1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb17349.x
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006) · Drug Target Insights · doi:10.33393/dti.2006.1296
Kohe, S. E., Gowing, E. K., Seo, S., Grattan, D. R., Kokay, I. C., Zheng, Y., Liu, P., & Oorschot, D. E. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107573
Metadata
- Authors
- Miller, H. H., Shore, P. A., & Clarke, D. E.
- Affiliations
- University of Houston (US)
- University of Texas Health Science Center at Dallas (US)
- Corresponding author
- Clarke, David E.
- ORCID
- Clarke, David E.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 1980-05
- Volume
- 29
- Issue
- 10
- Pages
- 1347-1354
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2032273250
- Cited by
- 120
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 2
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- d-amphetamine, L-amphetamine, monoamine oxidase inhibition, monoamine oxidase A, monoamine oxidase B, phenelzine, dopamine depletion, reserpine, cocaine, striatum
- MeSH terms
- Amphetamine, Animals, Brain, Cocaine, Corpus Striatum, Dextroamphetamine, Haloperidol, Male, Monoamine Oxidase Inhibitors, Phenelzine, 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-, 3,4-Dihydroxyphenylacetic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review